[go: up one dir, main page]

FI920566L - Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi Download PDF

Info

Publication number
FI920566L
FI920566L FI920566A FI920566A FI920566L FI 920566 L FI920566 L FI 920566L FI 920566 A FI920566 A FI 920566A FI 920566 A FI920566 A FI 920566A FI 920566 L FI920566 L FI 920566L
Authority
FI
Finland
Prior art keywords
aminotetrahydroacridines
derivatives
preparation
therapeutically useful
therapeutically
Prior art date
Application number
FI920566A
Other languages
English (en)
Swedish (sv)
Other versions
FI96308B (fi
FI920566A0 (fi
FI96308C (fi
Inventor
Gregory Michael Shutske
Kevin James Kapples
John Dick Tomer
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI920566A0 publication Critical patent/FI920566A0/fi
Publication of FI920566L publication Critical patent/FI920566L/fi
Publication of FI96308B publication Critical patent/FI96308B/fi
Application granted granted Critical
Publication of FI96308C publication Critical patent/FI96308C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/12Organo silicon halides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI920566A 1991-02-13 1992-02-11 Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi FI96308C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/654,691 US5210087A (en) 1991-02-13 1991-02-13 9-aminotetrahydroacridines and related compounds
US65469191 1991-02-13

Publications (4)

Publication Number Publication Date
FI920566A0 FI920566A0 (fi) 1992-02-11
FI920566L true FI920566L (fi) 1992-08-14
FI96308B FI96308B (fi) 1996-02-29
FI96308C FI96308C (fi) 1996-06-10

Family

ID=24625869

Family Applications (2)

Application Number Title Priority Date Filing Date
FI920566A FI96308C (fi) 1991-02-13 1992-02-11 Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi
FI945854A FI97056C (fi) 1991-02-13 1994-12-13 6,7-dihydro-3-(2-nitrofenyyli)bentsisoksatsol-4(5H)-oneja ja menetelmä niiden valmistamiseksi

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI945854A FI97056C (fi) 1991-02-13 1994-12-13 6,7-dihydro-3-(2-nitrofenyyli)bentsisoksatsol-4(5H)-oneja ja menetelmä niiden valmistamiseksi

Country Status (25)

Country Link
US (3) US5210087A (fi)
EP (1) EP0499231B1 (fi)
JP (1) JPH07121915B2 (fi)
KR (1) KR100223132B1 (fi)
AT (1) ATE153331T1 (fi)
AU (1) AU664165B2 (fi)
BR (1) BR9200475A (fi)
CA (1) CA2061084A1 (fi)
CZ (1) CZ281927B6 (fi)
DE (1) DE69219801T2 (fi)
DK (1) DK0499231T3 (fi)
ES (1) ES2102417T3 (fi)
FI (2) FI96308C (fi)
GR (1) GR3024310T3 (fi)
HU (1) HU219451B (fi)
IE (1) IE920459A1 (fi)
IL (3) IL117795A (fi)
MX (1) MX9200607A (fi)
NO (1) NO177933C (fi)
NZ (3) NZ270647A (fi)
PL (6) PL168153B1 (fi)
RO (1) RO112354B1 (fi)
RU (1) RU2083564C1 (fi)
TW (1) TW221426B (fi)
ZA (1) ZA921004B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
GB2264707A (en) * 1991-06-18 1993-09-08 Roger Michael Marchbanks Acridine derivatives for treating alzheimer's disease
ES2059263B1 (es) * 1992-10-27 1995-10-01 Vita Invest Sa Procedimiento para la obtencion del (+)-9-amino-1,2,3,4-tetrahidroacridin-1-ol.
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
ES2144353B1 (es) * 1997-12-26 2001-01-01 Consejo Superior Investigacion Nuevos analogos de tacrina: potenciales agentes neuroprotectores para las enfermedades de alzheimer y parkinson. su procedimiento de obtencion.
DE19830105C1 (de) * 1998-07-06 2000-02-17 Gruenenthal Gmbh Acridinderivate
WO2003076419A1 (en) 2002-03-08 2003-09-18 Japan Science And Technology Agency Isoxazole derivatives and process for producing the same
RU2616247C1 (ru) * 2016-03-28 2017-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments
MX13270A (es) * 1987-10-05 1993-06-01 Pfizer Procedimiento para la preparacion de derivados de 4-aminopiridina
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
GB8827704D0 (en) * 1988-11-28 1988-12-29 Fujisawa Pharmaceutical Co New acridine derivatives & processes for their production
US5441727A (en) * 1989-06-21 1995-08-15 The Procter & Gamble Company Diketone deodorant composition and method of deodorization
US5053513A (en) * 1990-03-29 1991-10-01 Hoechst-Roussel Pharmaceuticals Incorporated Method of reducing a carbonyl containing acridine
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
GB2264707A (en) * 1991-06-18 1993-09-08 Roger Michael Marchbanks Acridine derivatives for treating alzheimer's disease

Also Published As

Publication number Publication date
AU1090392A (en) 1992-08-20
EP0499231B1 (en) 1997-05-21
KR920016426A (ko) 1992-09-24
FI96308B (fi) 1996-02-29
DK0499231T3 (da) 1997-12-01
US5502203A (en) 1996-03-26
NO920547L (no) 1992-08-14
PL168153B1 (pl) 1996-01-31
IE920459A1 (en) 1992-08-12
HUT67032A (en) 1995-01-30
NZ270647A (en) 1996-02-27
ATE153331T1 (de) 1997-06-15
AU664165B2 (en) 1995-11-09
TW221426B (fi) 1994-03-01
ES2102417T3 (es) 1997-08-01
CS42692A3 (en) 1992-09-16
FI97056C (fi) 1996-10-10
HU219451B (hu) 2001-04-28
HU9200423D0 (en) 1992-04-28
CA2061084A1 (en) 1992-08-14
CZ281927B6 (cs) 1997-04-16
MX9200607A (es) 1992-11-30
US5210087A (en) 1993-05-11
PL296319A1 (en) 1993-07-12
IL100921A (en) 1998-12-27
DE69219801D1 (de) 1997-06-26
BR9200475A (pt) 1992-10-20
PL293443A1 (en) 1993-03-08
IL117795A (en) 1998-01-04
US5382594A (en) 1995-01-17
FI920566A0 (fi) 1992-02-11
FI945854L (fi) 1994-12-13
KR100223132B1 (ko) 1999-10-15
PL169095B1 (pl) 1996-05-31
FI96308C (fi) 1996-06-10
NZ241586A (en) 1996-02-27
FI945854A0 (fi) 1994-12-13
PL168906B1 (pl) 1996-05-31
FI97056B (fi) 1996-06-28
NO920547D0 (no) 1992-02-12
ZA921004B (en) 1992-10-28
DE69219801T2 (de) 1997-11-27
RO112354B1 (ro) 1997-08-29
JPH04312578A (ja) 1992-11-04
IL117795A0 (en) 1996-08-04
EP0499231A1 (en) 1992-08-19
PL296320A1 (en) 1993-07-12
NZ260694A (en) 1996-02-27
PL168862B1 (pl) 1996-04-30
NO177933B (no) 1995-09-11
NO177933C (no) 1995-12-20
PL166939B1 (pl) 1995-07-31
GR3024310T3 (en) 1997-10-31
RU2083564C1 (ru) 1997-07-10
JPH07121915B2 (ja) 1995-12-25
PL168861B1 (pl) 1996-04-30

Similar Documents

Publication Publication Date Title
FI925737A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten indol-3-yylialkyylipiperatsiinijohdannaisten valmistamiseksi
FI881900A7 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten substituoitujen imidatsolyylialkyylipiperatsiini- ja -diatsepiinijohdannaisten valmistamiseksi
FI914723A7 (fi) 17b-substituoituja 4-atsa-5a-androstan-3-oni-johdannaisia ja menetelmä niiden valmistamiseksi
FI953981A7 (fi) 2-Bentsyyli-polysykliset guaniinijohdannaiset ja menetelmä niiden valmistamiseksi
FI914905L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
FI874787A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI881223A7 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
FI953919A7 (fi) Pyrrolydeenimetyylijohdannaiset ja menetelmä niiden valmistamiseksi
FI891003A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-substituoitujen purinyylipiperatsiinijohdannaisten valmistamiseksi
FI900813A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bentsatsepiini- ja bentsotiatsepiinijohdannaisten valmistamiseksi
FI944713L (fi) 4-difenyylimetyylipiperidiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
FI905748A7 (fi) Menetelmä dopamiinin ja dopamiinijohdannaisten 4-O-fosfaattien valmis tamiseksi
FI884553A7 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
FI894604L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridyyli- ja pyrimidyylipiperatsiinijohdannaisten valmistamiseksi
FI891123A7 (fi) Menetelmä 1-syklopropyylikinolonikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
FI904838A7 (fi) Menetelmä farmaseuttisesti aktiivisten karboksitetrahydroisokinoliinien ja niiden johdannaisten valmistamiseksi
NO940027D0 (no) Fremgangsmaate for fremstilling av derivater av _fenylisoserin og derivatenes anvendelse
FI893426L (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten BU-3608-johdannaisten ja niiden suolojen valmistamiseksi
FI922343A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperidiini- ja pyrrolidiinijohdannaisten valmistamiseksi
FI920566L (fi) Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi
FI893677L (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-fluori-3,5-dihydroksikarboksyylihappojen ja niiden johdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL, INC.